Filter News
Area of Research
- (-) Advanced Manufacturing (2)
- (-) Fusion and Fission (7)
- (-) Fusion Energy (1)
- (-) Materials (45)
- (-) Neutron Science (44)
- Biology and Environment (13)
- Clean Energy (29)
- Computer Science (3)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Isotopes (1)
- Materials for Computing (5)
- National Security (17)
- Nuclear Science and Technology (5)
- Quantum information Science (1)
- Sensors and Controls (1)
- Supercomputing (29)
News Type
News Topics
- (-) Advanced Reactors (7)
- (-) Artificial Intelligence (6)
- (-) Chemical Sciences (23)
- (-) Cybersecurity (4)
- (-) Neutron Science (46)
- (-) Security (2)
- 3-D Printing/Advanced Manufacturing (22)
- Big Data (1)
- Bioenergy (9)
- Biology (8)
- Biomedical (7)
- Biotechnology (1)
- Buildings (3)
- Climate Change (5)
- Composites (3)
- Computer Science (11)
- Coronavirus (7)
- Critical Materials (8)
- Decarbonization (7)
- Energy Storage (21)
- Environment (12)
- Exascale Computing (1)
- Fossil Energy (1)
- Frontier (4)
- Fusion (12)
- Grid (4)
- High-Performance Computing (4)
- Irradiation (1)
- Isotopes (5)
- ITER (2)
- Machine Learning (4)
- Materials (45)
- Materials Science (41)
- Microscopy (14)
- Molten Salt (2)
- Nanotechnology (23)
- National Security (3)
- Net Zero (1)
- Nuclear Energy (17)
- Partnerships (11)
- Physics (16)
- Polymers (6)
- Quantum Computing (1)
- Quantum Science (12)
- Renewable Energy (1)
- Simulation (2)
- Space Exploration (1)
- Summit (4)
- Sustainable Energy (10)
- Transformational Challenge Reactor (2)
- Transportation (8)
Media Contacts
A collection of seven technologies for lithium recovery developed by scientists from ORNL has been licensed to Element3, a Texas-based company focused on extracting lithium from wastewater produced by oil and gas production.
Caldera Holding, the owner and developer of Missouri’s Pea Ridge iron mine, has entered a nonexclusive research and development licensing agreement with ORNL to apply a membrane solvent extraction technique, or MSX, developed by ORNL researchers to mined ores.
Guided by machine learning, chemists at ORNL designed a record-setting carbonaceous supercapacitor material that stores four times more energy than the best commercial material.
Anne Campbell, a researcher at ORNL, recently won the Young Leaders Professional Development Award from the Minerals, Metals & Materials Society, or TMS, and has been chosen as the first recipient of the Young Leaders International Scholar Program award from TMS and the Korean Institute of Metals and Materials, or KIM.
In a finding that helps elucidate how molten salts in advanced nuclear reactors might behave, scientists have shown how electrons interacting with the ions of the molten salt can form three states with different properties. Understanding these states can help predict the impact of radiation on the performance of salt-fueled reactors.
Using neutrons to see the additive manufacturing process at the atomic level, scientists have shown that they can measure strain in a material as it evolves and track how atoms move in response to stress.
ORNL has been selected to lead an Energy Earthshot Research Center, or EERC, focused on developing chemical processes that use sustainable methods instead of burning fossil fuels to radically reduce industrial greenhouse gas emissions to stem climate change and limit the crisis of a rapidly warming planet.
Using light instead of heat, researchers at ORNL have found a new way to release carbon dioxide, or CO2, from a solvent used in direct air capture, or DAC, to trap this greenhouse gas. The novel approach paves the way for economically viable separation of CO2 from the atmosphere.
The Spallation Neutron Source — already the world’s most powerful accelerator-based neutron source — will be on a planned hiatus through June 2024 as crews work to upgrade the facility. Much of the work — part of the facility’s Proton Power Upgrade project — will involve building a connector between the accelerator and the planned Second Target Station.
After a highly lauded research campaign that successfully redesigned a hepatitis C drug into one of the leading drug treatments for COVID-19, scientists at ORNL are now turning their drug design approach toward cancer.